SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher Kenney
Acorda Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Alabama at Birmingham
Birmingham, Alabama, United States
- Banner Sun Health Research Institute
Sun City, Arizona, United States
- Uc San Diego
La Jolla, California, United States
- Parkinson'S Disease & Movement Disorder Center of Boca Raton
Boca Raton, Florida, United States
- Augusta University
Augusta, Georgia, United States
- Northwestern University, Feinberg School of Medicine
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Iowa, Carver College of Medicine
Iowa City, Iowa, United States
- Parkinson'S Disease & Movement Disorder Center, University of Kansas Medical Center
Kansas City, Kansas, United States
- Department of Neurology, University of Maryland Parkinson'S Disease & Movement Disorder Center
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Struthers Parkinson'S Center
Golden Valley, Minnesota, United States
- Atlantic Neuroscience Institute
Summit, New Jersey, United States
- Duke University
Durham, North Carolina, United States
- Wake Forest Baptist Health Sciences
Winston-Salem, North Carolina, United States
- Parkinson'S Disease Movement Disorder Center
Philadelphia, Pennsylvania, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Baylor Univeristy
Houston, Texas, United States
- Houston Methodist Neurological Institute/movement Disorders Clinic
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Dec 2014
- Primary completion
- 3 Oct 2017
- Completion
- 3 Oct 2017
- Last update posted
- 19 Apr 2019
- Registered enrollment
- 82
- Registry id
- NCT02258152
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.